Search results for "report"

showing 10 items of 2364 documents

Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy

2017

The authors present a case of an 80-year-old Caucasian male with multiple gastric and rectal metastases from malignant melanoma presenting with hypochromic anemia as the sole symptom of disease without evidence of cutaneous and ocular tumor localization. The patient had a medical history positive for malignant lentigo melanoma of the occipital region of the scalp and early stage laryngeal squamous cell carcinoma and prostatic carcinoma treated with radiation therapy. The authors make some considerations on intestinal involvement by metastatic melanoma and discuss the choice of not treating with endoscopic procedures the gastric metastatic lesions most likely responsible for the clinical sig…

Oncologymedicine.medical_specialtymedicine.medical_treatmentCase ReportIpilimumabPembrolizumablcsh:RC254-28203 medical and health sciences0302 clinical medicineInternal medicinemedicineCarcinomaMedical historyStage (cooking)business.industryMelanomalcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseDermatologyRadiation therapyHypochromic anemiaOncology030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinessmelanoma rectal metastases immunotherapymedicine.drugCase Reports in Oncological Medicine
researchProduct

Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A case report of a multimodal treatment for peritoneal metastases…

2020

Highlights • Integration of PIPAC to systemic chemotherapy can have good tolerance profile. • Repeated biopsies performed during PIPAC allowed therapy-response monitoring. • Analysis of biopsies performed during PIPAC allowed tailoring of chemotherapy. • Integration of PIPAC to systemic chemotherapy can permit good quality of life.

Oncologymedicine.medical_specialtymedicine.medical_treatmentCase ReportPancreatic ductal adenocarcinoma03 medical and health sciences0302 clinical medicinePharmacokineticsQuality of lifeInternal medicinemedicineMultimodal treatmentAdverse effectChemotherapyPressurized intraperitoneal aerosol chemotherapy (PIPAC)CarcinomatosisSystemic chemotherapybusiness.industryStandard treatmentfungifood and beveragesPeritoneal metastases030220 oncology & carcinogenesisDrug delivery030211 gastroenterology & hepatologySurgerybusinessInternational Journal of Surgery Case Reports
researchProduct

Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Gr…

2021

Many cancer patients use integrative therapies with a combination of natural products and diets. In the Western world, integrative medicine is often not shared with oncologists even during antineoplastic treatments. This behavior stems from the unmet needs of cancer patients who may feel oncologists’ underestimation of their symptoms and spiritual aspects. This case report demonstrates the potential harm of inadequate diet and nutraceutical intake in a 68-year-old woman with metastatic estrogen receptor-positive, human epidermal growth factor receptor-2-negative breast cancer. Her care team recommended hormone therapy with abemaciclib plus fulvestrant. Her diarrhea started after 10 days of …

Oncologymedicine.medical_specialtymedicine.medical_treatmentEstrogen receptorCase ReportDiseaseBreast cancerInternal medicineEstrogen receptorMedicineRC254-282Fulvestrantbusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogensCancerMetastatic breast cancermedicine.diseaseMetastatic breast cancerAbemaciclibOncologyDetoxifying dietNutraceuticalsHormone therapyIntegrative medicinebusinessmedicine.drugCase Reports in Oncology
researchProduct

The Role of Medicinal Mushrooms in Brain Cancer Therapies: Review.

2021

Medicinal mushrooms are considered an unlimited source of polysaccharides (mainly β-glucans) and polysaccharide-protein complexes and possess various immunological and anticancer properties. In addition, their use in integrative medicine leads to a clear reduction of side effects in patients undergoing chemotherapy or radiotherapy. The literature reports a number of beneficial effects of using mushrooms as health supplements in patients affected by high-grade glioma. The effects of medicinal mushrooms on side effects in patients with brain cancer and a case study report are also described in this review.

Oncologymedicine.medical_specialtymedicine.medical_treatmentMEDLINEApplied Microbiology and BiotechnologyBrain cancerStudy reportPolysaccharidesInternal medicineGliomaDrug DiscoverymedicineHumansIn patientintegrative therapies brain cancer glioblastoma medicinal mushrooms mycotherapeutic supportPharmacologyChemotherapybusiness.industryBrain Neoplasmsmedicine.diseaseRadiation therapySettore BIO/03 - Botanica Ambientale E ApplicataDietary SupplementsIntegrative medicinebusinessAgaricalesInternational journal of medicinal mushrooms
researchProduct

Rituximab plus chemotherapy provides no clinical benefit in a peripheral T-cell lymphoma not otherwise specified with aberrant expression of CD20 and…

2020

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is the most common entity of mature T-cell neoplasms. PTCL-NOS generally has an aggressive behavior and is often refractory to standard therapy. Only a few cases of PTCL with aberrant expression of B-cell antigens have been reported so far. This phenotypic aberrancy may lead to misdiagnosis as B-cell non-Hodgkin lymphomas and eventual inappropriate patient management, whereas in an accurately diagnosed PTCL, the presence of CD20 may appear as an appealing therapeutic target. In this setting, response to anti-CD20 monoclonal antibody in combination with chemotherapy has been poorly explored. We describe the case of a 59-year-old …

Oncologyperipheral t-cell lymphomamedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryPeripheral T-cell lymphoma not otherwise specifiedCase ReportSettore MED/08 - Anatomia Patologicarituximab.03 medical and health sciences0302 clinical medicinerituximabimmune system diseasesInternal medicinehemic and lymphatic diseasesMedicineb-cell antigens; cd20; cd79a; peripheral t-cell lymphoma; rituximabCD20cd79aperipheral T-cell lymphomaB-cell antigenCD20lcsh:R5-920Chemotherapybiologybusiness.industryNot Otherwise Specifiedcd20CD79amedicine.diseaseCD79APeripheral T-cell lymphomaLymphomab-cell antigens030220 oncology & carcinogenesisbiology.proteinRituximablcsh:Medicine (General)business030215 immunologymedicine.drug
researchProduct

The BaBar detector: Upgrades, operation and performance

2013

The BABAR detector operated successfully at the PEP-Il asymmetric e(+) e(-) collider at the SLAC National Accelerator Laboratory from 1999 to 2008. This report covers upgrades, operation, and performance of the collider and the detector systems, as well as the trigger, online and offline computing, and aspects of event reconstruction since the beginning of data taking.

Online and offlinePhysics - Instrumentation and DetectorsGeneral-purpose detector for colliding beamPhysics::Instrumentation and DetectorsBABARSettore ING-INF/01 - Elettronica01 natural sciences/dk/atira/pure/sustainabledevelopmentgoals/clean_water_and_sanitationlaw.inventionHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)lawBeam monitoringPEP2[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Ream monitoringInstrumentationQCEvent reconstructionPhysicsoperational experience; high-luminosity storage ring operation; beam monitoring; general-purpose detector for colliding beamsGeneral-purpose detector for colliding beamsDetectorElectrical engineeringInstrumentation and Detectors (physics.ins-det)upgrade [detector]:Mathematics and natural scienses: 400::Physics: 430::Nuclear and elementary particle physics: 431 [VDP]Beam monitoring; General-purpose detector for colliding beams; High-luminosity storage ring operation; Operational experience; Nuclear and High Energy Physics; InstrumentationPARTICLE PHYSICSFísica nuclearPARTICLE PHYSICS;PEP2;BABARSDG 6 - Clean Water and SanitationperformanceNuclear and High Energy PhysicsFOS: Physical sciencesNuclear physics0103 physical sciencesddc:530[PHYS.PHYS.PHYS-INS-DET]Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det]010306 general physicsCollideractivity report010308 nuclear & particles physicsbusiness.industryHigh-luminosity storage ring operation:Matematikk og naturvitenskap: 400::Fysikk: 430::Kjerne- og elementærpartikkelfysikk: 431 [VDP]Operational experienceExperimental High Energy PhysicsBaBarPhysics::Accelerator PhysicsHigh Energy Physics::Experimentbusiness
researchProduct

An Agenda for Open Science in Communication

2021

Contains fulltext : 226720.pdf (Publisher’s version ) (Open Access) In the last 10 years, many canonical findings in the social sciences appear unreliable. This so-called "replication crisis" has spurred calls for open science practices, which aim to increase the reproducibility, replicability, and generalizability of findings. Communication research is subject to many of the same challenges that have caused low replicability in other fields. As a result, we propose an agenda for adopting open science practices in Communication, which includes the following seven suggestions: (1) publish materials, data, and code; (2) preregister studies and submit registered reports; (3) conduct replicatio…

Open scienceLinguistics and LanguageRegistered Reportsmedia_common.quotation_subject/dk/atira/pure/subjectarea/asjc/3300/3315050801 communication & media studies050105 experimental psychologyLanguage and Linguistics0508 media and communicationsPromotion (rank)Open Science/dk/atira/pure/subjectarea/asjc/3300/3310Political scienceReplicabilityOpenness to experience0501 psychology and cognitive sciencesGeneralizability theoryPublicationmedia_commonReplication crisis/dk/atira/pure/subjectarea/asjc/1200/1203business.industryCommunication05 social sciencesPreregistrationPublic relations/dk/atira/pure/sustainabledevelopmentgoals/quality_educationTransparency (behavior)ReproducibilityCommunication and MediaPsychologieddc:320businessSDG 4 - Quality EducationQualitative research
researchProduct

The largest bilateral gemination of permanent maxillary central incisors: report of a case

2013

Gemination is defined as an attempt to make two teeth from one enamel organ. Bilateral presentation of this phenomenon is very rare, with prevalence of 0.01% to 0.04% in the primary, and 0.05% in the permanent dentition. This paper describes a rare case of huge bilateral gemination of permanent maxillary central incisors in a nine-year-old Iranian boy with poor aesthetic. The patient did not have history of anomaly in his primary dentition and in his family either. This type of dental anomaly can cause clinical problems in the form of malocclusion, poor aesthetic, and impaction of adjacent teeth, caries, and periodontal destruction. Key words:Gemination, central incisor, bilateral.

Oral Medicine and PathologyDentitionbusiness.industryImpactionPermanent dentitionEnamel organDentistryCase ReportOdontologíamedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludstomatognathic diseasesstomatognathic systemGeminationUNESCO::CIENCIAS MÉDICASMedicineMaxillary central incisorPresentation (obstetrics)MalocclusionbusinessGeneral Dentistry
researchProduct

Synchronous occurrence of two lateral periodontal cysts in the same patient. Report of a rare case and review of the literature

2020

We present a case of a patient with two lateral periodontal cysts in the maxilla and the mandible, respectively, and review the English literature on multiple lateral periodontal (LPCs) cysts and/or gingival cysts (GCs) and botryoid odontogenic cysts (BOCs). The patient was a 59 year-old female with two fluctuant swellings covered by semi-lucent mucosa on the attached gingiva between the maxillary and mandibular right canine and first premolar teeth, respectively. Periapical radiographs revealed at the respective sites between the roots of the canine and first premolar teeth areas unilocular radiolucencies. Intra-operatively, the presence of bone cavities was confirmed at both sites. The mi…

Oral Medicine and Pathologybusiness.industryLateral periodontal cystRadiographyMandibleDentistryCase Report030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]03 medical and health sciencesstomatognathic diseases0302 clinical medicinemedicine.anatomical_structureOdontogenic cyststomatognathic system030220 oncology & carcinogenesisMaxillaPeriodontal CystUNESCO::CIENCIAS MÉDICASmedicinePremolarDifferential diagnosisbusinessGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct

Congenital lower lip pits : Van der Woude syndrome

2018

The Van der Woude syndrome is a rare autosomal dominant development malformation characterized by a paramedian lip pits and /or sinuses or conical elevation of lower lip associated with cleft lip and or palate. These congenital lip pits usually appear clinically in the vermilion border of lip, with or without secretion. The critical region of VWS has been identified to be at Iq32 to 41 with high, but incomplete penetrance and variable expressivity. Therapeutic intervention is generally required for cosmetic reason or when recurrent inflammation is present. Dental surgeon should be aware of this syndrome, as it is associated with variety of other congenital malformation. van der woude syndro…

Oral Medicine and Pathologybusiness.industryLower lipRecurrent inflammationCase ReportAnatomymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Penetrance03 medical and health sciencesstomatognathic diseases0302 clinical medicinemedicine.anatomical_structurestomatognathic systemBilateral cleft lip030225 pediatricsUNESCO::CIENCIAS MÉDICASmedicineVan der Woude syndrome030212 general & internal medicineVermilion borderbusinessGeneral DentistryCongenital lower lip pits
researchProduct